Chemed (CHE) Gets a Hold Rating from JMP Securities
JMP Securities analyst Peter Martin maintained a Hold rating on Chemed (CHE) on February 25. The company’s shares closed yesterday at $326.45, close to its 52-week high of $335.99.
According to TipRanks.com, Martin is a 1-star analyst with an average return of -0.3% and a 54.1% success rate. Martin covers the Financial sector, focusing on stocks such as MedEquities Realty Trust, Five Point Holdings Llc, and Medical Properties.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Chemed with a $329 average price target, implying a 0.8% upside from current levels. In a report issued on February 25, RBC Capital also maintained a Hold rating on the stock with a $318 price target.
See today’s analyst top recommended stocks >>
Chemed’s market cap is currently $5.2B and has a P/E ratio of 26.66. The company has a Price to Book ratio of 9.15.
Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.